789 results on '"Nieweg, Omgo E"'
Search Results
2. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
3. ASO Visual Abstract: Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas
4. ASO Visual Abstract: Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
5. Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma
6. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
7. Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases
8. Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
9. The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma
10. ASO Author Reflections: The Clinical Relevance of Sentinel Nodes in Minor Lymph Node Fields Such as the Triangular Intermuscular Space in Patients with Melanoma
11. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
12. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
13. ASO Visual Abstract: Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma
14. Histological regression in melanoma: impact on sentinel lymph node status and survival
15. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
16. Inguinofemoral, Iliac/Obturator, and Popliteal Lymphadenectomy for Melanoma
17. Lymphoscintigraphy in Patients with Melanoma
18. The Sentinel Lymph Node Concept
19. Anatomy and Physiology of Lymphatic Circulation: Application to Lymphatic Mapping
20. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma
21. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma
22. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
23. ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases
24. Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
25. Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction
26. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease
27. Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis
28. Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients
29. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
30. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
31. Radioguided Sentinel Lymph Node Mapping and Biopsy in Cutaneous Melanoma
32. Radioguided Monitoring of Systemic Leakage During Isolated Limb Perfusion for Melanoma
33. Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al.
34. ASO Visual Abstract: Survival Outcomes of Salvage Metastasectomy after Failure of Modern-Era Systemic Therapy for Melanoma
35. Composite haemangioendothelioma with neuroendocrine marker differentiation presenting as a pink–brown nodule.
36. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
37. Sentinel Lymph Node
38. Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients
39. False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma
40. Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens
41. Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival
42. Sentinel node biopsy in cutaneous melanoma patients with germline CDKN2A mutations
43. Isolated Limb Perfusion for Melanoma
44. Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma
45. Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases
46. Lymphoscintigraphy in Patients with Melanoma
47. Inguinofemoral, Iliac/Obturator, and Popliteal Lymphadenectomy for Melanoma
48. Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma
49. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
50. Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.